These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis. Rauthu SR; Shiao TC; André S; Miller MC; Madej É; Mayo KH; Gabius HJ; Roy R Chembiochem; 2015 Jan; 16(1):126-39. PubMed ID: 25407851 [TBL] [Abstract][Full Text] [Related]
5. Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8. Oberg CT; Blanchard H; Leffler H; Nilsson UJ Bioorg Med Chem Lett; 2008 Jul; 18(13):3691-4. PubMed ID: 18539029 [TBL] [Abstract][Full Text] [Related]
7. Quinoline-galactose hybrids bind selectively with high affinity to a galectin-8 N-terminal domain. Pal KB; Mahanti M; Huang X; Persson S; Sundin AP; Zetterberg FR; Oredsson S; Leffler H; Nilsson UJ Org Biomol Chem; 2018 Aug; 16(34):6295-6305. PubMed ID: 30117507 [TBL] [Abstract][Full Text] [Related]
8. Rational Design and Synthesis of Methyl-β-d-galactomalonyl Phenyl Esters as Potent Galectin-8 Patel B; Kishor C; Houston TA; Shatz-Azoulay H; Zick Y; Vinik Y; Blanchard H J Med Chem; 2020 Oct; 63(20):11573-11584. PubMed ID: 32809817 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of stable and selective inhibitors of human galectins-1 and -3. Giguère D; Bonin MA; Cloutier P; Patnam R; St-Pierre C; Sato S; Roy R Bioorg Med Chem; 2008 Aug; 16(16):7811-23. PubMed ID: 18674915 [TBL] [Abstract][Full Text] [Related]
10. Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: role of electrostatic potential at O-3. Giguère D; Sato S; St-Pierre C; Sirois S; Roy R Bioorg Med Chem Lett; 2006 Mar; 16(6):1668-72. PubMed ID: 16403629 [TBL] [Abstract][Full Text] [Related]
11. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions. Sörme P; Kahl-Knutsson B; Huflejt M; Nilsson UJ; Leffler H Anal Biochem; 2004 Nov; 334(1):36-47. PubMed ID: 15464951 [TBL] [Abstract][Full Text] [Related]
12. 1-O-Substituted derivatives of murrayafoline A and their antifungal properties. Cuong NM; Wilhelm H; Porzel A; Arnold N; Wessjohann L Nat Prod Res; 2008; 22(16):1428-32. PubMed ID: 19023805 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of Galectin Inhibitors by Regioselective 3'- Belkhadem K; Cao Y; Roy R Molecules; 2020 Dec; 26(1):. PubMed ID: 33383774 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and galectin-binding activities of mercaptododecyl glycosides containing a terminal β-galactosyl group. Murakami T; Yoshioka K; Sato Y; Tanaka M; Niwa O; Yabuki S Bioorg Med Chem Lett; 2011 Feb; 21(4):1265-9. PubMed ID: 21237642 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and molecular recognition of carbohydrate-centered multivalent glycoclusters by a plant lectin RCA120. Gao Y; Eguchi A; Kakehi K; Lee YC Bioorg Med Chem; 2005 Nov; 13(22):6151-7. PubMed ID: 16054373 [TBL] [Abstract][Full Text] [Related]